University of Lorraine-ko ikertzaileekin lankidetzan egindako argitalpenak (44)

2023

  1. A New Integrative and Mobilizable Element Is a Major Contributor to Tetracycline Resistance in Streptococcus dysgalactiae subsp. equisimilis

    Antibiotics, Vol. 12, Núm. 3

  2. EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 25, Núm. 4, pp. 1249-1276

  3. Liver injury in hospitalized patients with COVID-19: An International observational cohort study

    PLoS ONE, Vol. 18, Núm. 9 September

  4. Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe

    ESMO Open, Vol. 8, Núm. 5

2022

  1. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

    The Lancet Diabetes and Endocrinology, Vol. 10, Núm. 1, pp. 35-45

2021

  1. Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease models

    Scientific Reports, Vol. 11, Núm. 1

  2. Management of anaphylaxis due to COVID-19 vaccines in the elderly

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 10, pp. 2952-2964

  3. Protecting older patients with cardiovascular diseases from COVID-19 complications using current medications

    European Geriatric Medicine, Vol. 12, Núm. 4, pp. 725-739

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Covariate adjusted reanalysis of the I-Preserve trial

    Clinical Research in Cardiology, Vol. 109, Núm. 11, pp. 1358-1365

  3. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  4. Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)/diazepam binding inhibitor (DBI)

    Cell Death and Disease, Vol. 11, Núm. 7

2019

  1. CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) axis in cardiac fibrosis and inflammation: Mechanistic insights and clinical implications

    Hypertension, Vol. 73, Núm. 3, pp. 602-611

  2. Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma

    Leukemia

  3. Expert consensus document: Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure

    European Journal of Heart Failure, Vol. 21, Núm. 7, pp. 844-851

  4. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

    Nature Communications, Vol. 10, Núm. 1

  5. Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition

    Scientific Reports, Vol. 9, Núm. 1

  6. Soluble ST2 promotes oxidative stress and inflammation in cardiac fibroblasts: An in vitro and in vivo study in aortic stenosis

    Clinical Science, Vol. 133, Núm. 14, pp. 1537-1548

2018

  1. A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: Analysis of the FIRST trial

    Leukemia, Vol. 32, Núm. 6, pp. 1404-1413

  2. Aldosterone Impairs Mitochondrial Function in Human Cardiac Fibroblasts via A-Kinase Anchor Protein

    Scientific Reports, Vol. 8, Núm. 1